Risk factor
Very poor trading liquidity
Profitability factor
Excellent dividends
About
Ratchaphruek Hospital Public Company Limited, known as Ratchaphruek Hospital, runs a healthcare facility in Thailand, delivering a comprehensive array of medical services. Its extensive offerings encompass various specialties, including internal medicine (such as dermatology, neurology, hematology, pulmonology, rheumatology, gastroenterology, nephrology, diabetes and endocrine care, and cardiology), a range of surgical procedures (general, urological, and colorectal), and specialized treatments in areas like pediatrics, orthopedics, ear-nose-throat (ENT), ophthalmology, obstetrics and gynecology, preventative health check-ups, dentistry, anesthesiology, emergency care, stroke management, breast health, hearing and balance, rehabilitation, and diagnostic radiology. The hospital also supplies medicines and medical provisions. Incorporated in 1993 in Khon Kaen, Thailand, the company was initially named Sithan Karnpat Company Limited, changing to its current designation in September 2016.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB